Kenvue completes global agency review; WPP wins creative, Publicis takes media & commerce

The consumer health major, with an estimated $1.35 billion global media spend in 2025, has split duties between WPP and Publicis Groupe following a worldwide agency review

by e4m Staff
Published: Dec 23, 2025 9:27 AM | 1 min read

Kenvue completes global agency review; WPP wins creative, Publicis takes media & commerce

Kenvue has concluded a global agency review by appointing WPP and Publicis Groupe as its new worldwide agency partners, according to a global report.

Under the new arrangement, WPP will take charge of creative leadership and production across Kenvue’s portfolio, spanning all channels and markets, with the exception of Neutrogena.

Publicis Groupe, on the other hand, will handle media, commerce, healthcare communications and technology services for all Kenvue brands, while also managing creative and production duties for Neutrogena. Publicis already oversees Kenvue’s media business in the Asia-Pacific region.

The review covered Kenvue’s global brand portfolio, which includes household names such as Tylenol, Listerine and Neutrogena. As per COMvergence estimates cited in the report, the company’s global media spend stood at approximately $1.35 billion in 2025.

The timing of the agency appointment is significant for Kenvue, particularly for Tylenol, which went through a turbulent phase over the past year. The brand found itself at the centre of public debate in 2025 after the Trump administration raised concerns around the use of acetaminophen during pregnancy—claims that were strongly challenged by the medical community. In response, Kenvue maintained a measured, evidence-based communications stance as legal proceedings unfolded.

The review also coincides with broader leadership changes at Kenvue. In October 2025, the company appointed Jon Halvorson to a newly created role that combines global marketing leadership with digital commerce strategy.